Singapore markets closed

Alar Pharmaceuticals Inc. (6785.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
250.50+3.00 (+1.21%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
-
469,272
800
0
600
Operating expenses
Research development
64,929
56,713
34,182
81,888
160,328
Selling general and administrative
24,423
27,032
13,145
11,407
11,037
Total operating expenses
89,352
83,745
47,327
93,295
171,365
Operating income or loss
379,920
385,527
-46,527
-93,295
-170,765
Interest expense
53
63
22
21
33
Income before tax
426,057
391,106
-32,538
-64,231
-142,797
Income tax expense
14,776
8,490
-12,667
0
0
Income from continuing operations
411,281
382,616
-19,871
-64,231
-142,797
Net income
411,281
382,616
-19,871
-64,231
-142,797
Net income available to common shareholders
411,281
382,616
-19,871
-64,231
-142,797
Basic EPS
-0.37
6.71
-0.35
-1.13
-2.86
Diluted EPS
-0.37
6.71
-0.35
-1.13
-2.86
Basic average shares
57,000
57,000
57,000
57,000
49,907
Diluted average shares
57,000
57,051
57,000
57,000
49,907